|
1
|
Christopherson WM, Foote FW Jr and Stewart
FW: Alveolar soft-part sarcomas; Structurally characteristic tumors
of uncertain histogenesis. Cancer. 5:100–111. 1952. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Auerbach HE and Brooks JJ: Alveolar soft
part sarcoma: A clinicopathologic and immunohistochemical study.
Cancer. 60:66–73. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bu X and Bernstein L: A proposed
explanation for female predominance in alveolar soft part sarcoma.
Noninactivation of X; autosome translocation fusion gene? Cancer.
103:1245–1253. 2005.
|
|
4
|
Ordóñez NG: Alveolar soft part sarcoma: A
review and update. Adv Anat Pathol. 6:125–139. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Flieder DB, Moran CA and Suster S: Primary
alveolar soft-part sarcoma of the mediastinum: A
clinicopathological and immunohistochemical study of two cases.
Histopathology. 31:469–473. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hunter BC, Devaney KO, Ferlito A and
Rinaldo A: Alveolar soft partsarcoma of the head and neck region.
Ann Otol Rhinol Laryngol. 107:810–814. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lieberman PH, Brennan MF, Kimmel M,
Erlandson RA, Garin-Chesa P and Flehinger BY: Alveolar soft-part
sarcoma: A clinico-pathologic study of half a century. Cancer.
63:1–13. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oniki T, Hashimoto Y, Fujinuma Y, Maruyama
Y, Namba K, Yajima M, Numano F and Maezawa H: Hypervascular
metastaticcardiac tumors: An unknown cause of mitral valve
prolapse. Intern Med. 31:78–81. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O'Sullivan B, Davis AM, Turcotte R, Bell
R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, et
al: Preoperative versus postoperative radiotherapy in soft-tissue
sarcoma of the limbs: A randomised trial. The Lancet.
359:2235–2241. 2002. View Article : Google Scholar
|
|
10
|
Reichardt P, Lindner T, Pink D,
Thuss-Patience PC, Kretzschmar A and Dörken B: Chemotherapy in
alveolar soft part sarcomas. What do we know? Eur J Cancer.
39:1511–1516. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Smetana HF and Scott WF Jr: Malignant
tumors of nonchromaffin paraganglia. Mil Surg. 109:330–349.
1951.PubMed/NCBI
|
|
12
|
Zhang LL, Tang Q, Wang Z and Zhang XS:
Alveolar soft part sarcoma of the uterine corpus with pelvic lymph
node metastasis: Case report and literature review. Int J Clin Exp
Pathol. 5:715–719. 2012.PubMed/NCBI
|
|
13
|
Yavuz A, Göya C, Bora A and Beyazal M:
Primary alveolar soft part sarcoma of the scapula. Case Rep Oncol.
6:356–361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mannan R, Bhasin TS, Kaur P, Manjari M and
Gill KS: Prominent intracytoplasmic crystals in alveolar soft part
sarcoma (ASPS): An aid in cytological diagnosis. J Clin Diagn Res.
8:145–146. 2014.PubMed/NCBI
|
|
15
|
Kummar S, Allen D, Monks A, Polley EC,
Hose CD, Ivy SP, Turkbey IB, Lawrence S, Kinders RJ, Choyke P, et
al: Cediranib for metastatic alveolar soft part sarcoma. J Clin
Oncol. 31:2296–2302. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cho YJ and Kim JY: Alveolar soft part
sarcoma: Clinical presentation, treatment and outcome in a series
of 19 patients. Clin Orthop Surg. 6:80–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Akiyama Y, Baba T, Ibayashi Y, Asai Y and
Houkin K: Alveolar soft part sarcoma in brain with cardiac
metastasis: A case report. Int J Cardiol. 114:e93–e95. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Campbell B, Seymour JF, Wheeler G and
Sexton M: Alveolar soft-part sarcoma: A cardiac metastasis as a
rare site of relapse. Am J Clin Oncol. 29:422–423. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Butany J, Nair V, Naseemuddin A, Nair GM,
Catton C and Yau T: Cardiac tumours: Diagnosis and management.
Lancet Oncol. 6:219–228. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Smith NR, James NH, Oakley I, Wainwright
A, Copley C, Kendrew J, Womersley LM, Jürgensmeier JM, Wedge SR and
Barry ST: Acute pharmacodynamic and antivascular effects of the
vascular endothelial growth factor signaling inhibitor AZD2171 in
Calu-6 human lung tumor xenografts. Mol Cancer Ther. 6:2198–2208.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wedge SR, Kendrew J, Hennequin LF,
Valentine PJ, Barry ST, Brave SR, Smith NR, James NH, Dukes M,
Curwen JO, et al: AZD2171: A highly potent, orally bioavailable,
vascular endothelial growth factor receptor-2 tyrosine kinase
inhibitor for the treatment of cancer. Cancer Res. 65:4389–4400.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Portera CA Jr, Ho V, Patel SR, Hunt KK,
Feig BW, Respondek PM, Yasko AW, Benjamin RS, Pollock RE and
Pisters PW: Alveolar soft part sarcoma: Clinical course and
patterns of metastasis in 70 patients treated at a single
institution. Cancer. 91:585–591. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iwamoto Y, Morimoto N, Chuman H, Shinohara
N and Sugioka Y: The role of MR imaging in the diagnosis of
alveolar soft part sarcoma: A report of 10 cases. Skeletal Radiol.
24:267–270. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suh JS, Cho J, Lee SH, Shin KH, Yang WI,
Lee JH, Cho JH, Suh KJ, Lee YJ and Ryu KN: Alveolar soft part
sarcoma: MR and angiographic findings. Skeletal Radiol. 29:680–689.
2000. View Article : Google Scholar : PubMed/NCBI
|
